April 24, 2013 / 11:11 AM / 5 years ago

GSK opts to sell off Lucozade and Ribena drink brands

LONDON, April 24 (Reuters) - GlaxoSmithKline has decided to sell its popular soft drink brands Lucozade and Ribena in a disposal that could bring in more than 1 billion pounds ($1.5 billion).

The move was announced on Wednesday alongside weak first-quarter results, which saw sales at Britain’s biggest drugmaker drop 3 percent from a year ago.

GSK launched a strategic review of the two brands earlier this year, ruling nothing in or out for their future. Most analysts had focused on the idea of a sale, which is likely to attract interest from private equity and trade buyers.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below